` HIKAL (Hikal Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

HIKAL
vs
BSE Sensex 30

Over the past 12 months, HIKAL has significantly outperformed BSE Sensex 30, delivering a return of 38% compared to the BSE Sensex 30's 3% growth.

Stocks Performance
HIKAL vs BSE Sensex 30

Loading
HIKAL
BSE Sensex 30
Add Stock

Performance Gap
HIKAL vs BSE Sensex 30

Loading
HIKAL
BSE Sensex 30
Difference

Performance By Year
HIKAL vs BSE Sensex 30

Loading
HIKAL
BSE Sensex 30
Add Stock

Competitors Performance
Hikal Ltd vs Peers

BSE Sensex 30
HIKAL
LLY
JNJ
NOVO B
ROG
Add Stock

Hikal Ltd
Glance View

Market Cap
49.5B INR
Industry
Pharmaceuticals

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

HIKAL Intrinsic Value
355.09 INR
Overvaluation 11%
Intrinsic Value
Price
Back to Top